title: Aprotinin revisited: rebuttal of comments by DeSantis and Lazaridis.
authors.affiliation: Bristol Heart Institute , University of Bristol, Bristol, BS8 1TH, UK.
authors.forename: G J
authors.initials: GJ
authors.lastname: Walkden
authors.forename: R
authors.initials: R
authors.lastname: Goudie
authors.forename: V
authors.initials: V
authors.lastname: Verheyden
authors.forename: G J
authors.initials: GJ
authors.lastname: Murphy
mesh_terms: D007611:Aprotinin / Q000009:adverse effects* / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D005260:Female; D006490:Hemostatics / Q000009:adverse effects* / Q000627:therapeutic use*; D017052:Hospital Mortality / Q000639:trends*; D006801:Humans; D008297:Male
chemical_list: D006490:Hemostatics; D007611:Aprotinin